{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:28:38Z","timestamp":1761182918768,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jiac.2017.04.014","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T01:00:38Z","timestamp":1494637238000},"page":"798-799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Guillain\u2013Barr\u00e9 syndrome in a patient with renal cell carcinoma following the first course of pazopanib therapy"],"prefix":"10.1016","volume":"23","author":[{"given":"Hiroaki","family":"Koshikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Tsukie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Fujikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.04.014_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.critrevonc.2016.08.012","article-title":"First-line antiangiogenics for metastatic renal cell carcinoma: a systematic review and network meta-analysis","volume":"107","author":"Rousseau","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jiac.2017.04.014_bib2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1200\/JCO.2008.21.6994","article-title":"Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma","volume":"28","author":"Huston","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jiac.2017.04.014_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2017.04.014_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jiac.2017.04.014_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/WCO.0b013e32834a87b7","article-title":"Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations","volume":"24","author":"Koike","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jiac.2017.04.014_bib6","article-title":"Guillain-Barr\u00e9 syndrome following treatment with sunitinib malate","author":"Kanaan","year":"2014","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.jiac.2017.04.014_bib7","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1535-7163.MCT-10-1124","article-title":"New insight into molecular mechanisms of sunitinib-associated side effects","volume":"10","author":"Aparicio-Gallego","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jiac.2017.04.014_bib8","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4","article-title":"Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome","volume":"21","author":"Watanabe","year":"1998","journal-title":"Muscle Nerve"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17301046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17301046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:04Z","timestamp":1761159424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17301046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1341321X17301046"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.04.014","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guillain\u2013Barr\u00e9 syndrome in a patient with renal cell carcinoma following the first course of pazopanib therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}